United States · FDA National Drug Code directory
purelax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59779-306_56426544-544c-4632-b5dd-568d1787f578
- Product NDC
- 59779-306
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- CVS Pharmacy
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091007
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 119 g in 1 BOTTLE (59779-306-01) · 59779-306-01
- 238 g in 1 BOTTLE (59779-306-02) · 59779-306-02
- 510 g in 1 BOTTLE (59779-306-03) · 59779-306-03
- 850 g in 1 BOTTLE (59779-306-04) · 59779-306-04
- 765 g in 1 BOTTLE (59779-306-09) · 59779-306-09
- 10 POUCH in 1 CARTON (59779-306-52) / 17 g in 1 POUCH · 59779-306-52
- 20 POUCH in 1 CARTON (59779-306-60) / 17 g in 1 POUCH · 59779-306-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →